Akari Therapeutics plc ADR (0.01 USD) (AKTX) is a publicly traded Healthcare sector company. As of August 26, 2026, AKTX trades at $8.14 with a market cap of $14.54M and a P/E ratio of 0.00. AKTX moved +0.00% today. Year to date, AKTX is -32.16%; over the trailing twelve months it is -77.77%. Its 52-week range spans $3.02 to $69.20. Analyst consensus is buy with an average price target of $28.50. Rallies surfaces AKTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest AKTX news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $8.14 |
| Market Cap | $14.54M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $69.20 |
| 52-Week Low | $3.02 |
| Volume | 18.91K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-17.30M |
| Gross Margin | 0.00% |
2 analysts cover AKTX: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $28.50.